Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press12710.17650/1726-9776-2013-9-3-70-75REVIEWОБЗОРSATURATION BIOPSY OF THE PROSTATE (REVIEW)САТУРАЦИОННАЯ БИОПСИЯ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ)SadchenkoA. V.СадченкоА. В.
Russian Federation

Department of Urology

кафедра урологии

doc.sadchenko@yandex.ruGovorovA. V.ГоворовА. В.
Russian Federation

Department of Urology

кафедра урологии

doc.sadchenko@yandex.ruPushkarD. Yu.ПушкарьД. Ю.
Russian Federation

Department of Urology

кафедра урологии

doc.sadchenko@yandex.ruVasilievA. O.ВасильевА. О.
Russian Federation

Department of Urology

кафедра урологии

doc.sadchenko@yandex.ruMSMSUМГМСУ им. А.И. Евдокимова300920139370752707201427072014https://oncourology.abvpress.ru/oncur/article/view/127

Prostate biopsy is the principal method of diagnois of prostate cancer, allowing to start the adequate treatment. The tactics of the patients, which have negative initial biopsy, is a subject of discussion. Saturation biopsy is a “gold standard„ of diagnostics of PCA with repeat biopsy. Saturation biopsy of the prostate is not a primary procedure, usually apply in patients with negative biopsies in anamnesis, patients with multifocal PIN and ASAP. Saturation biopsy allows to more precisely predict the volume and degree of malignancy of PCA, that can be used for planning tactics of active surveillance and focal therapy.

Биопсия предстательной железы является основным методом диагностики рака предстательной железы (РПЖ), позволяющим начать своевременное адекватное лечение. Тактика ведения больных, у которых первичная биопсия была отрицательной, остается предметом дискуссии. «Золотым стандартом» диагностики РПЖ при повторной биопсии является сатурационная биопсия. Сатурационная биопсия предстательной железы не показана как первичная процедура, обычно она используется у мужчин с отрицательными биопсиями в анамнезе, но с сохраняющимся подозрением на РПЖ, у пациентов с мультифокальной простатической интраэпителиальной неоплазией и наличием атипичной мелкоацинарной пролиферации. Сатурационная биопсия позволяет более точно прогнозировать объем и степень злокачественности опухоли, что может быть использовано для планирования тактики лечения.

prostate biopsysaturation biopsytransrectal biopsytransperineal biopsyprostate cancerбиопсия предстательной железысатурационная биопсиятрансректальная биопсиятрансперинеальная биопсиярак предстательной железы1. Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1);10–29.Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1);10–29.2. Hodge K.K., McNeal J.E., Terris M.K. et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142;71–5.Hodge K.K., McNeal J.E., Terris M.K. et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142;71–5.3. Говоров А.В. Оптимизация трансректальной биопсии простаты в диагностике рака предстательной железы. Автореф. дис. … канд. мед. наук. М., 2002.Говоров А.В. Оптимизация трансректальной биопсии простаты в диагностике рака предстательной железы. Автореф. дис. … канд. мед. наук. М., 2002.4. Berger A.P., Gozzi C., Steiner H. et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171;1478–80, discussion 1480–1.Berger A.P., Gozzi C., Steiner H. et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171;1478–80, discussion 1480–1.5. Eskew L.A., Bare R.L., Mc Cullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157;199–202, discussion 202–3.Eskew L.A., Bare R.L., Mc Cullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157;199–202, discussion 202–3.6. Kawakami S., Okuno T., Yonese J. et al. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of threedimensional 26-core systematic biopsy. Eur Urol 2007;51;675–82, discussion 682–3.Kawakami S., Okuno T., Yonese J. et al. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of threedimensional 26-core systematic biopsy. Eur Urol 2007;51;675–82, discussion 682–3.7. Bertaccini A., Fandella A., Prayer-Galetti T. Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project. Anticancer Res 2007;27;659–66.Bertaccini A., Fandella A., Prayer-Galetti T. Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project. Anticancer Res 2007;27;659–66.8. Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166;86–92.Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166;86–92.9. Borboroglu P.G., Corner S.W., Riffenburgh R.H. et al. Extensive repeat transrectal ultrasound-guided prostate biopsy in patient with previous benign sextant biopsies. J Urol 2000;163;158–62.Borboroglu P.G., Corner S.W., Riffenburgh R.H. et al. Extensive repeat transrectal ultrasound-guided prostate biopsy in patient with previous benign sextant biopsies. J Urol 2000;163;158–62.10. Ploussard G., Nicolaiew N., Marchand C. Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy. Eur Urol 2012; pii: S0302-2838(12)00633-1.Ploussard G., Nicolaiew N., Marchand C. Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy. Eur Urol 2012; pii: S0302-2838(12)00633-1.11. Campos-Fernandes J.L., Bastien L., Nicolaiew N. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009;55(3);600–6.Campos-Fernandes J.L., Bastien L., Nicolaiew N. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 2009;55(3);600–6.12. Lane B.R., Zippe C.D., Abouassaly A. et al. Saturation technique does not decrease cancer detection during follow-up after initial prostate biopsy. J Urol 2008;179;1749–50.Lane B.R., Zippe C.D., Abouassaly A. et al. Saturation technique does not decrease cancer detection during follow-up after initial prostate biopsy. J Urol 2008;179;1749–50.13. Jones J.S., Patel A., Schoenfield L. et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006;175(2);485.Jones J.S., Patel A., Schoenfield L. et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006;175(2);485.14. Велиев Е.И., Обейд А., Богданов А.Б. Целесообразность первичной сатурационной биопсии в выявлении локализованного рака предстательной железы после радикальной простатэктомии. Онкоурология 2011;(5):43–5.Велиев Е.И., Обейд А., Богданов А.Б. Целесообразность первичной сатурационной биопсии в выявлении локализованного рака предстательной железы после радикальной простатэктомии. Онкоурология 2011;(5):43–5.15. Maccagnano C., Gallina A., Scattoni V. et al. Prostate saturation biopsy following a first negative biopsy: state of the art. Urol Int 2012;89;126–35.Maccagnano C., Gallina A., Scattoni V. et al. Prostate saturation biopsy following a first negative biopsy: state of the art. Urol Int 2012;89;126–35.16. Demura T., Hioka T., Furuno T. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 2005;103;1826–32.Demura T., Hioka T., Furuno T. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 2005;103;1826–32.17. Yan W., Li H., Zhou Y. Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy. Urol Oncol 2009;27(5);520–4.Yan W., Li H., Zhou Y. Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy. Urol Oncol 2009;27(5);520–4.18. Moore C.K., Karikehalli S., Nazeer T. et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173(1);70–2.Moore C.K., Karikehalli S., Nazeer T. et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173(1);70–2.19. Gallo F., Chiono L., Gastaldi E. et al. Prognostic significance of highgrade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. J Urol 2008;72;628–32.Gallo F., Chiono L., Gastaldi E. et al. Prognostic significance of highgrade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. J Urol 2008;72;628–32.20. Merrimen J.L., Jones G., Srigley J.R. Is highgrade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology 2010;42;325–9.Merrimen J.L., Jones G., Srigley J.R. Is highgrade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology 2010;42;325–9.21. Merrimen J.L., Jones G., Walker D. et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009;182;485–90.Merrimen J.L., Jones G., Walker D. et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009;182;485–90.22. Wolters T., van der Kwast T.H., Vissers C.J. et al. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up. Am J Surg Pathol 2010;34;35–43.Wolters T., van der Kwast T.H., Vissers C.J. et al. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up. Am J Surg Pathol 2010;34;35–43.23. Klotz L. Active surveillance for prostate cancer: a review. Arch Esp Urol 2011;64;806–14.Klotz L. Active surveillance for prostate cancer: a review. Arch Esp Urol 2011;64;806–14.24. Scattoni V., Zlotta A., Montironi R. et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007;52;1309–22.Scattoni V., Zlotta A., Montironi R. et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007;52;1309–22.25. Bul M., van den Bergh R.C., Rannikko A. Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. Eur Urol 2012;61;370–7.Bul M., van den Bergh R.C., Rannikko A. Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. Eur Urol 2012;61;370–7.26. Berg C.D., Andriole G.L., Crawford E.D. et al. Mortality results from a randomized prostate-cancer screening trial. J Natl Cancer Inst 2009;360;1310–9.Berg C.D., Andriole G.L., Crawford E.D. et al. Mortality results from a randomized prostate-cancer screening trial. J Natl Cancer Inst 2009;360;1310–9.27. Scardino P.T., Abenhaim L.L. Focal therapy for prostate cancer: analysis by an international panel. J Urol 2008;72;1–2.Scardino P.T., Abenhaim L.L. Focal therapy for prostate cancer: analysis by an international panel. J Urol 2008;72;1–2.28. Mouraviev V., Mayes J.M., Madden J.F. et al. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat 2007;6;91–5.Mouraviev V., Mayes J.M., Madden J.F. et al. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat 2007;6;91–5.29. Falzarano S.M., Zhou M., Hernandez A.V. et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. J Urol 2010;76;682–7.Falzarano S.M., Zhou M., Hernandez A.V. et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. J Urol 2010;76;682–7.30. Onik G., Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26;506–10.Onik G., Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26;506–10.31. De La Rosette J., Ahmed H., Barentsz J. et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol 2010;24(5):775–80.De La Rosette J., Ahmed H., Barentsz J. et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol 2010;24(5):775–80.32. Epstein J.I., Ploussard G., Montironi R. et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 2011;60;291–303.Epstein J.I., Ploussard G., Montironi R. et al. The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 2011;60;291–303.33. Zaytoun O.M., Moussa A.S., Gao T. et al. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol 2011;186(3);850–4.Zaytoun O.M., Moussa A.S., Gao T. et al. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol 2011;186(3);850–4.34. Li H., Yan W., Zhou Y. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. J Urol 2007;70;1157–61.Li H., Yan W., Zhou Y. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. J Urol 2007;70;1157–61.35. AbdollahF., NovaraG., Briganti A. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 2011;77;921–5.AbdollahF., NovaraG., Briganti A. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? Urology 2011;77;921–5.36. Watanabe M., Hayashi T., Tsushima T. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol 2005;12;969–73.Watanabe M., Hayashi T., Tsushima T. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol 2005;12;969–73.37. Hossack T., Patel M.I., Huo A. et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 2012;188;781–5.Hossack T., Patel M.I., Huo A. et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol 2012;188;781–5.38. Djavan B., Waldert M., Zlotta A. et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166;856–60.Djavan B., Waldert M., Zlotta A. et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166;856–60.39. Carlsson S.V., Holmberg E., Moss S.M. et al. No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer. BJU Int 2011;107;1912–7.Carlsson S.V., Holmberg E., Moss S.M. et al. No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer. BJU Int 2011;107;1912–7.40. Hara R., Jo Y., Fujii T., Kondo N. et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. J Urol 2008;71;191–5.Hara R., Jo Y., Fujii T., Kondo N. et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. J Urol 2008;71;191–5.41. Zhang F.B., Shao Q., Du Y., Tian Y. Ultrasoundguided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA < 20 microg/L. Zhonghua Nan Ke Xue 2012;18(4);306–9.Zhang F.B., Shao Q., Du Y., Tian Y. Ultrasoundguided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA < 20 microg/L. Zhonghua Nan Ke Xue 2012;18(4);306–9.